Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
1 093,811 096,521 100,221 091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
1 254,811 253,011 253,871 226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
1 761,111 764,271 766,881 744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
3 211,833 227,213 268,383 226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
1 474,521 479,031 481,041 466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
2 392,122 396,952 421,222 382,32
4559:TYO
Zeria Pharmaceutical Co Ltd
2 132,00 JP¥
-1,25%
(-27,00) 1K
1-may, 15:30:00 (GMT+9)  ·   JPY
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
4559 tikeri uchun statistika yaratilmoqda...
Ochish
2 155 JP¥
Yuqori
2 156 JP¥
Past
2 123 JP¥
Bozor kapitali
106,85 mlrd
Oʻrtacha hajm
96,12 ming
Hajmi
54,00 ming
Dividend
2,25%
Choraklik dividendlar
12 JP¥
Eks-dividend sanasi
29-sen, 2025
P/E koeffitsiyenti
12,94
52 haftalik eng yuqori
2 378 JP¥
52 haftalik eng past
1 878 JP¥
Aksiya boʻyicha daromad
165 JP¥
Muomaladagi aksiyalar
50,11 mln
Xodimlar soni
2 ming
Yangiliklar
Internetdagi manbalardan
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Zeria Pharmaceutical Co Ltd haqida
CEOSachiaki Ibe
Xodimlar soni1,75 ming
Asos solingan22-dek, 1955
Bosh ofislar-
Sektor-
Veb-saytzeria.co.jp
Avvalgi hisobotlarBarcha qiymatlar – JPY
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – JPY
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
22,54 mlrd
19,49 mlrd
20,47 mlrd
24,12 mlrd
Sotilgan mahsulotning tannarxi
6,05 mlrd
5,58 mlrd
5,59 mlrd
6,38 mlrd
Daromad narxi
6,05 mlrd
5,58 mlrd
5,59 mlrd
6,38 mlrd
Tadqiqot va ishlanmalarga xarajatlar
4,11 mlrd
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
4,58 mlrd
12,39 mlrd
12,76 mlrd
12,82 mlrd
Operatsion xarajatlar
14,54 mlrd
12,39 mlrd
12,76 mlrd
12,82 mlrd
Jami operatsion xarajatlar
20,59 mlrd
17,97 mlrd
18,35 mlrd
19,19 mlrd
Operatsion daromad
1,95 mlrd
1,52 mlrd
2,12 mlrd
4,93 mlrd
Boshqa nooperatsion daromad
-51,00 mln
25,00 mln
-23,00 mln
-81,04 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
2,16 mlrd
1,66 mlrd
994,00 mln
4,63 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
2,18 mlrd
1,66 mlrd
994,00 mln
4,63 mlrd
Daromad soligʻi boʻyicha xarajat
397,00 mln
624,00 mln
383,00 mln
795,44 mln
Amaldagi soliq stavkasi
18,34%
37,61%
38,53%
-
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
1,71 mlrd
1,09 mlrd
647,00 mln
3,82 mlrd
Sof foyda marjasi
7,59%
5,59%
3,16%
-
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
95,00 mln
279,00 mln
30,00 mln
136,71 mln
Foizlarni toʻlash xarajatlari
-114,00 mln
-121,00 mln
-119,00 mln
-123,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-19,00 mln
158,00 mln
-89,00 mln
13,71 mln
Amortizatsiya ajratmalari
5,85 mlrd
-
-
-
EBITDA
3,84 mlrd
3,41 mlrd
3,88 mlrd
6,81 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil